Category: Workers Comp

529 posts found

FDA Declares Semaglutide Shortage Over

The GLP-1 receptor agonist has been considered in shortage since 2022, but the FDA confirmed with manufacturers that presented and projected demand can now be met.

This Month's Must Read

4 Ways PBMs Can Improve the Workers’ Comp Experience

PBMs can reduce burden for payers, provide intuitive claims tools, provide effective customer support, and engage injured workers.

Image of Healthcare worker looking stressed

Legislation & Policy

PTSD Presumptions Continue to See Activity

New York backpedaled on a PTSD presumption for all workers, while California considers a PTSD presumption for healthcare workers.

Clinical Insights

WCRI Reports on the Pandemic’s Impact on Medical Utilization

Despite decreases in injury frequency across all groups, younger workers still saw higher use of emergency departments.

Psychedelic Developments

Psilocybin and Ketamine Therapy Bills Introduced Across the Country

So far, seven psilocybin therapy bills have been introduced in 2025, with three ketamine therapy bills.

Healthe Developments

Healthesystems Announces Key Promotion to Support Innovation in Data Analytics

Mike Theis has been promoted to AVP, Product Analytics and Business Strategy

Medmonitor

FDA Approves Novel Non-Opioid Journavx for Moderate to Severe Pain

A first-in-class medication, Journavx targets pain-signaling pathways involving sodium channels.

This Month's Must Read

2025 Workers’ Comp Industry Insights Survey Report

The seventh annual survey report highlights the top challenges and priorities for 515 industry stakeholders.

Legislation & Policy

Flurry of States Eye Updates for Cancer and PTSD Presumptions

Various states are proposing modifications to existing presumptions to expand coverage for first responders.

Opioid Developments

Cebranopadol Phase 3 Trials Show Promising Results

A compound opioid/NOP receptor agonist demonstrated pain relief with a safety profile comparable to placebo.

Clinical Developments

WCRI Reports on Changes in the Medical Workforce and the Impact on Claims

Pandemic driven increases to provider vacancies have increased reliance on nurse practitioners and physician assistants.

Healthe Developments

A Hot Topic: The Latest News on Workers and Extreme Heat

Recent data insights, state proposals, and updates on federal rulemaking procedures.

Medmonitor

FDA Approves Generic GLP-1 Victoza Injections for Type 2 Diabetes

Victoza® (liraglutide) injections are a GLP-1 receptor agonist, a drug class experiencing shortages due to their high demand.

This Month's Must Read

From A-to-Z: 5 Population Considerations for Gen Z

Health trends to consider in this growing portion of the workforce.

Innovation

FDA Issues Draft Guidance for the Use of AI in the Creation of Drugs and Medical Devices

The guidelines provide recommendations on using AI to demonstrate drug safety and effectiveness, and recommendations for AI-enabled medical devices.

Prev 1 2 3 4 5 … 32 33 34 35 36 Next